Outpatient Treatment Available for Mild to Moderate COVID-19: Updated 1/11/22
Jan 11, 2021
Updated January 11, 2022
Monoclonal antibody therapy is the first COVID-19 treatment granted emergency use authorization by the U.S. Food and Drug Administration for outpatient care.
Spectrum Health Lakeland is providing monoclonal antibody treatment within the COVID-19 Medication Therapies space at the Center for Outpatient Services, located at 3900 Hollywood Road in St. Joseph. The drug is administered one time through a vein (intravenous or IV). The infusion takes 20-30 minutes followed by a 60 minute monitoring period. Total visit times take around 2 hours.
Monoclonal antibody treatment is a scarce resource and eligibility for treatment is dependent on medication supply and demand. Due to limited supply of monoclonal antibodies, and the time-sensitive nature of the treatment, we are not able to accommodate every treatment request. Following the medical and ethical recommendations of the CDC, FDA, and NIH, the limited supply of monoclonal antibodies will be used in the case of greatest need, where the treatment will bring the greatest benefit. Spectrum Health is making every attempt to obtain a sufficient supply of monoclonal antibodies so that we can offer treatment to as many patients as possible.
Eligibility
To be considered for this treatment option at a Spectrum Health location, patients must be 12 years of age or older, weigh at least 88 pounds and meet each of the following initial criteria:
- Positive COVID-19 test
- COVID-19 related symptom(s) present for 7 days or less
- Patient is not hospitalized
- Patient has risk factors that increase likelihood of hospitalization.
As supply allows, mAb therapy can also be used for prevention of COVID-19 in people who have had close contact or are at high risk of being in
close contact with someone with COVID-19, such as people in the same institutional setting (for example, nursing homes or prisons) where COVID-19 is circulating or for people with a close contact (within 6 feet for at least 15 minutes) of a person who is positive for COVID-19.
Patients should not seek monoclonal antibody treatment in the emergency department. Monoclonal antibody treatment is not available in the emergency department.
Other material to review while considering treatment:
SOTROVIMAB-Patient-Fact-Sheet (English)
Sotrovimad-eua-fact-sheet-for-patients-in-spanish (Spanish)
If you have tested positive for COVID-19 and think monoclonal antibody treatment may be right for you, talk with their primary care provider to determine if you qualify. To find additional mAb therapy providers,
click here.
Frequently Asked Questions
If I receive monoclonal antibodies, can I still get the COVID-19 vaccine?
Yes; you can get the COVID-19 vaccine, and we encourage you to get vaccinated. The Centers for Disease Control and Prevention recommends waiting 90 days after receiving monoclonal antibodies since monoclonal antibodies and vaccine can interact and decrease long-term protection.
Does my quarantine duration change after I receive this infusion?
No; your quarantine time will remain the same. Despite the anticipated improvement in your symptoms, you will still be contagious. Please continue isolating, wearing a mask and practicing good handwashing.